- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07379853
Interactive E-Learning for Therapist Training in Exposure Therapy
January 30, 2026 updated by: Bradley Hospital
The project involves the development of an eLearning platform to train therapists in the delivery of exposure therapy for clients with anxiety disorders and OCD.
Following initial development, clinician end users will complete rounds of iterative feedback to inform final development, at which point, therapists will be recruited to complete the entire training program in an open trial.
Study Overview
Status
Enrolling by invitation
Intervention / Treatment
Detailed Description
Despite the existence of numerous well-established evidence-based practices (EBPs) for mental disorders, it has been difficult to disseminate these practices in community settings.
Exposure therapy for anxiety disorders represents one of the most glaring examples of this research-to- practice gap.
Many practicing therapists have never had the opportunity to receive training in exposure therapy and cite this as a primary barrier to its delivery.
To address this gap, investigators need to rethink the way in which they train providers.
Recent advances in e-learning offer an exciting opportunity to automate both the didactic and interactive components of these evidence-based training modules-an approach that has potential to vastly improve scalability, thus addressing a primary barrier to accessing the most potent treatment available for anxiety.
In this project, the team will develop and initially test an automated eLearning approach for therapists learning exposure therapy.
The investigators will leverage evidence-based training content and strategies from their prior work, as well as recent advances in eLearning (e.g., adaptive eLearning).
The proposed Phase I STTR study will take place in three stages.
Stage one (Development) is a nine-month development period during which PARC Innovations will build an alpha version of the training program in accordance with specifications from the research team and early input from a Multi-perspective Advisory Panel (MAP).
The MAP (N=8) will consist of professionals with expertise in commercialization, education & e-learning, and/or technology.
In Stage two (End- User Feedback and Optimization), a group of clinician end-users (N = 8) will interact with the platform and provide quantitative and qualitative feedback that will be synthesized by the research team into action items for further development.
In stage three (Training Trial), therapists (N=40) will complete 8 hours of e-learning training (self-paced) over three weeks.
Usability and training outcomes (e.g., therapist knowledge, self-efficacy) from this pilot trial will support a Phase II STTR project aimed at building out and broadly disseminating this eLearning approach.
Study Type
Interventional
Enrollment (Estimated)
56
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rhode Island
-
Riverside, Rhode Island, United States, 02915
- Bradley Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- A practicing therapist providing psychotherapy
- Providing treatment for clients with anxiety conditions
Exclusion Criteria:
- Not employed as a mental health provider
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Open Training Trial
Therapist will complete the entire eLearning training program
|
Therapist training in Exposure Therapy delivery using an eLearning platform
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Therapist Beliefs about Exposure (TBES)
Time Frame: Immediately before initiating the training program and immediately after completing the 10-hour training intervention.
|
The TBES is a well-validated, 21-item likert measure of therapist reservations about exposure therapy delivery.
Total scores range from 0-84 with higher scores representing more reservations about using exposure therapy with clients.
|
Immediately before initiating the training program and immediately after completing the 10-hour training intervention.
|
|
System Usability Scale (SUS)
Time Frame: Immediately before starting the training program and immediately after completing the 10-hour training intervention
|
The SUS is a well-validated measure of usability and acceptability of new innovations.
This measure is especially common in the evaluation of new software systems.
The measure consists of a 10-item measure on a 5-point likert scale.
The scale is converted to a 0-100 score with higher scores indicating higher levels of perceived usability.
|
Immediately before starting the training program and immediately after completing the 10-hour training intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 17, 2025
Primary Completion (Estimated)
March 31, 2027
Study Completion (Estimated)
March 31, 2027
Study Registration Dates
First Submitted
January 22, 2026
First Submitted That Met QC Criteria
January 27, 2026
First Posted (Actual)
February 2, 2026
Study Record Updates
Last Update Posted (Actual)
February 3, 2026
Last Update Submitted That Met QC Criteria
January 30, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R41MH139194 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ANXIETY DISORDERS (or Anxiety and Phobic Neuroses)
-
University of OsloNot yet recruitingMajor Depression Disorder | ANXIETY DISORDERS (or Anxiety and Phobic Neuroses)Norway
-
Duke UniversityBaylor College of Medicine; Yale University; Icahn School of Medicine at Mount... and other collaboratorsCompletedANXIETY DISORDERS (or Anxiety and Phobic Neuroses)United States
-
Lund UniversityRecruitingGeneralized Anxiety Disorder | Social Anxiety Disorder | Panic Disorder | Separation Anxiety Disorder | Specific Phobia | Agoraphobia | ANXIETY DISORDERS (or Anxiety and Phobic Neuroses)Sweden
-
University of NottinghamLincolnshire Partnership NHS Foundation TrustCompletedDepression - Major Depressive Disorder | ANXIETY DISORDERS (or Anxiety and Phobic Neuroses)United Kingdom
-
Eli Lilly and CompanyCompletedAnxiety Neuroses | Anxiety States, Neurotic | Neuroses, AnxietyUnited States, Mexico, South Africa
-
Indiana UniversityIndiana University HealthEnrolling by invitationDepressive Disorder | ANXIETY DISORDERS (or Anxiety and Phobic Neuroses) | Conduct Disorders in Children | Implementation Research | Pediatric Mental Health ServicesUnited States
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)RecruitingAnhedonia | Phobic Disorders | Social Anxiety Disorder (Social Phobia) | ANXIETY DISORDERS (or Anxiety and Phobic Neuroses) | Public Speaking AnxietyUnited States
-
PfizerCompletedAnxiety NeurosesSpain, Belgium, South Africa, Germany, United Kingdom, Poland, Austria, Estonia, France, Israel, Italy, Latvia, Netherlands, Ukraine
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
University of BernCompletedSocial Anxiety | Social Anxiety DisorderSwitzerland
Clinical Trials on Therapist Training
-
University of AlbertaCompletedSpastic DiplegiaCanada
-
Ohio State UniversityCompletedAutism Spectrum DisorderUnited States
-
NYU Langone HealthAmerican Occupational Therapy FoundationCompleted
-
University Hospital, MontpellierUniversity of Bristol; Université Montpellier; Ecole Polytechnique Fédérale de... and other collaboratorsUnknown
-
Wroclaw University of Health and Sport SciencesCompletedStroke | Muscle Spasticity | Upper Extremity Dysfunction | Hemiparesis | Subacute StrokePoland
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedCardiorespiratory FailureUnited States
-
University Hospital OlomoucPalacky UniversityRecruiting
-
University of California, San DiegoNational Institute of Mental Health (NIMH)Withdrawn
-
Oregon Health and Science UniversityNot yet recruitingRehabilitation | Developmental Disability | Assistive Technology | Early Intervention | Cerebral Palsy Children | Motor DisabilitiesUnited States
-
North Norway Rehabilitation CenterUniversity of Oslo; University of Tromso; Loma Linda University; Norwegian School... and other collaboratorsCompletedSpinal Cord InjuryNorway